|Dexfenfluramine||St. John's wort|
|Toxic rapeseed oil||Chemotherapeutic agents|
|Benfluorex||Interferon α and β|
↵∗ Nice 2013.
↵† Selective serotonin reuptake inhibitor (SSRIs) have been demonstrated as a risk factor for the development of persistent pulmonary hypertension in the newborn (PPHN) in pregnant women exposed to SSRIs (especially after 20 weeks of gestation). PPHN does not strictly belong to Group 1 (pulmonary arterial hypertension [PAH]) but to a separated Group 1. Main modification to the previous Danapoint classification are in bold.